FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

María Jesús Pérez-Elías

Research Profile

Disorders

Living Beings

HIV-1

Chemicals & Drugs

Procedures

Concepts & Ideas

Geographic Areas

Spain

Physiology

Viral Drug Resistance

Co-author Network

Publications

TOP 3
Carolina Gutiérrez; Beatriz Hernández-Novoa; Africa Holguín; Ana María Moreno; José Luis Casado; Fernando Dronda; María Jesús Pérez-Elías; Santiago Moreno
Prevalence of primary resistance mutations to integrase inhibitors in treatment-naïve and -experienced patients infected with B and non-B HIV-1 variants.
José L Casado; Ignacio de Los Santos; María Del Palacio; Lucio García-Fraile; María Jesús Pérez-Elías; Jesús Sanz; Santiago Moreno
Lipid-lowering effect and efficacy after switching to etravirine in HIV-infected patients with intolerance to suppressive HAART.
Ana Moreno; María Jesús Pérez-Elías; Carmen Quereda; Miguel A Rodríguez-Sagrado; Rafael Bárcena; José L Casado; Santos del Campo; Fernando Dronda; María Luisa Mateos; Marisa Montes; Santiago Moreno
Safe coadministration of raltegravir-based HAART in HIV-infected patients with HCV-cirrhosis receiving triple therapy with telaprevir or boceprevir.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of María Jesús Pérez-Elías (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Carolina Gutiérrez; Beatriz Hernández-Novoa; Africa Holguín; Ana María Moreno; José Luis Casado; Fernando Dronda; María Jesús Pérez-Elías; Santiago Moreno
Prevalence of primary resistance mutations to integrase inhibitors in treatment-naïve and -experienced patients infected with B and non-B HIV-1 variants.
HIV clinical trials 2013;14(1):10-6.
2013: José L Casado; Ignacio de Los Santos; María Del Palacio; Lucio García-Fraile; María Jesús Pérez-Elías; Jesús Sanz; Santiago Moreno
Lipid-lowering effect and efficacy after switching to etravirine in HIV-infected patients with intolerance to suppressive HAART.
HIV clinical trials 2013;14(1):1-9.
2012: Ana Moreno; María Jesús Pérez-Elías; Carmen Quereda; Miguel A Rodríguez-Sagrado; Rafael Bárcena; José L Casado; Santos del Campo; Fernando Dronda; María Luisa Mateos; Marisa Montes; Santiago Moreno
Safe coadministration of raltegravir-based HAART in HIV-infected patients with HCV-cirrhosis receiving triple therapy with telaprevir or boceprevir.
Journal of acquired immune deficiency syndromes (1999) 2012;61(3):e47-9.
2012: María Martínez Colubi; Fernando Dronda; Laura Elías; Dolores López; Santiago Moreno; Alfonso Muriel; María Jesús Pérez-Elías; María Pumares; Ana Moreno Zamora; Jose Luis Casado
Missing scheduled visits in the outpatient clinic as a marker of short-term admissions and death.
HIV clinical trials 2012;13(5):289-95.
2011: Federico García; Vicente Guillot; Maria López-Dieguez; Santiago Pérez-Cachafeiro; María Jesús Pérez-Elías; Pilar Pérez-Romero; Isabel Viciana; Marta Alvarez; Jose Ramón Blanco; Carmen de Mendoza
Transmission of HIV drug resistance and non-B subtype distribution in the Spanish cohort of antiretroviral treatment naïve HIV-infected individuals (CoRIS).
Antiviral research 2011;91(2):150-3.
2011: Gonzalo Yebra; Miguel de Mulder; Juan-Carlos Galán; Jara Llenas-García; Santiago Moreno; María Jesús Pérez-Elías; José A Pérez-Molina; Africa Holguín
Increase of transmitted drug resistance among HIV-infected sub-Saharan Africans residing in Spain in contrast to the native population.
PloS one 2011;6(10):e26757.
2010: Ana Moreno; Carmen Quereda; Jesús Fortún; Rafael Bárcena; María Jesús Pérez-Elías; José L Casado; Miguel A Rodríguez-Sagrado; María L Mateos; Carlos Blesa; Santiago Moreno
Safe co-administration of raltegravir, pegylated-interferon and, ribavirin in HIV individuals with hepatitis C virus-related liver damage.
AIDS (London, England) 2010;24(8):1231-3.
2010: Ana Moreno; María Jesús Pérez-Elías; José L Casado; Jesús Fortún; Rafael Bárcena; Carmen Quereda; Santos del Campo; Carmen Gutiérrez; Oscar Pastor; Javier Nuño; Ana Fernandez; Santiago Moreno
Raltegravir-based highly active antiretroviral therapy has beneficial effects on the renal function of human immunodeficiency virus-infected patients after solid organ transplantation.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2010;16(4):530-2.
2009: María Jesús Pérez-Elías; Ana Moreno; José Luis Casado; Fernando Dronda; Antonio Antela; Dolores López; Carmen Quereda; Enrique Navas; Jose Manuel Hermida; E Del Sol; Santiago Moreno
Observational study to evaluate clinical outcomes after first-line efavirenz-or lopinavir-ritonavir-based HAART in treatment-naive patients.
Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002) 2009;8(5):308-13.
2009: César Garriga; María Jesús Pérez-Elías; Rafael Delgado; Lidia Ruiz; Lucía Pérez-Alvarez; Tomás Pumarola; Ana López Lirola; Juan González-García; Luis Menéndez-Arias
HIV-1 reverse transcriptase thumb subdomain polymorphisms associated with virological failure to nucleoside drug combinations.
The Journal of antimicrobial chemotherapy 2009;64(2):251-8.
2009: María Jesús Pérez-Elías; Jose María Gatell; Juan Flores; Jesús Santos; Francisco Vera-Médez; Bonaventura Clotet; Ana Moreno; Jose-Antonio Pérez-Molina; Belén Vendrell; Oscar Serrano
Short-term effect of ritonavir-boosted atazanavir in hepatitis B and/or C co-infected, treatment-experienced HIV patients.
HIV clinical trials 2009;10(4):269-75.
2009: Iñigo Corral; Carmen Quereda; Ana Moreno; María Jesús Pérez-Elías; Fernando Dronda; José-Luis Casado; Alfonso Muriel; Jaime Masjuán; María Alonso de Leciñana; Santiago Moreno
Cerebrovascular ischemic events in HIV-1-infected patients receiving highly active antiretroviral therapy: incidence and risk factors.
Cerebrovascular diseases (Basel, Switzerland) 2009;27(6):559-63.
2008: Carmen Quereda; Iñigo Corral; Ana Moreno; María Jesús Pérez-Elías; José L Casado; Fernando Dronda; Miguel A Rodríguez-Sagrado; Beatríz Hernández; Santiago Moreno
Effect of treatment with efavirenz on neuropsychiatric adverse events of interferon in HIV/HCV-coinfected patients.
Journal of acquired immune deficiency syndromes (1999) 2008;49(1):61-3.
2008: B Hernández-Novoa; Antonio Antela; C Gutiérrez; JA Pérez-Molina; María Jesús Pérez-Elías; Fernando Dronda; Ana Moreno; José L Casado; C Page; M Pumares; Juan-Carlos Galán; Santiago Moreno
Effect of food on the antiviral activity of didanosine enteric-coated capsules: a pilot comparative study.
HIV medicine 2008;9(4):187-91.
2008: Ana Moreno; Rafael Bárcena; Carmen Quereda; José L Casado; María Jesús Pérez-Elías; Jesús Fortún; Javier Nuño; Isabel Arranz; Santiago Moreno
Safe use of raltegravir and sirolimus in an HIV-infected patient with renal impairment after orthotopic liver transplantation.
AIDS (London, England) 2008;22(4):547-8.
2007: César Garriga; María Jesús Pérez-Elías; Rafael Delgado; Lidia Ruiz; Rafael Nájera; Tomás Pumarola; María del Mar Alonso-Socas; Silvia García-Bujalance; Luis Menéndez-Arias
Mutational patterns and correlated amino acid substitutions in the HIV-1 protease after virological failure to nelfinavir- and lopinavir/ritonavir-based treatments.
Journal of medical virology 2007;79(11):1617-28.
2007: María Jesús Pérez-Elías
Atazanavir: simplicity and convenience in different scenarios.
Expert opinion on pharmacotherapy 2007;8(5):689-700.
2007: Josep Maria Llibre-Codina; Miguel Angel Casado-Gómez; Rainel Sánchez-de la Rosa; María Jesús Pérez-Elías; Jesús Santos González; Celia Miralles-Alvarez; Esteban Martínez-Chamorro; Pere Domingo Pedrol; María Luisa Alvarez-García; Santiago Moreno-Guillén
[Cost of nucleoside analogue reverse transcriptase inhibitor-related toxicity in HIV-1-infected patients].
Enfermedades infecciosas y microbiología clínica 2007;25(2):98-107.
2007: Brendan Larder; Dechao Wang; Andrew Revell; Julio Montaner; Richard Harrigan; Frank De Wolf; Joep Lange; Scott Wegner; Lidia Ruiz; María Jesús Pérez-Elías; Sean Emery; José M Gatell; Antonella d'Arminio Monforte; Carlo Torti; Maurizio Zazzi; Clifford Lane
The development of artificial neural networks to predict virological response to combination HIV therapy.
Antiviral therapy 2007;12(1):15-24.
2006: Beatriz Hernández; Santiago Moreno; María Jesús Pérez-Elías; José L Casado; Fernando Dronda; Ana Moreno; Antonio Antela
Severity of the toxicity associated with combinations that include didanosine plus stavudine in HIV-infected experienced patients.
Journal of acquired immune deficiency syndromes (1999) 2006;43(5):556-9.
2006: Ana Moreno; Alberto Moreno; María Jesús Pérez-Elías; Carmen Quereda; Rafael Fernández Muñoz; Antonio Antela; Leonor Moreno; Rafael Bárcena; Antonio López-San Román; María Luisa Celma; María García-Martos; Santiago Moreno
Syncytial giant cell hepatitis in human immunodeficiency virus-infected patients with chronic hepatitis C: 2 cases and review of the literature.
Human pathology 2006;37(10):1344-9.
2006: Ana Moreno; Rafael Bárcena; Silvia García-Garzón; Leonor Moreno; Carmen Quereda; Alfonso Muriel; Javier Zamora; María Luisa Mateos; María Jesús Pérez-Elías; Antonio Antela; Sergio Diz; A Moreno; Santiago Moreno
Viral kinetics and early prediction of nonresponse to peg-IFN-alpha-2b plus ribavirin in HCV genotypes 1/4 according to HIV serostatus.
Journal of viral hepatitis 2006;13(7):466-73.
2006: Josep M Llibre; Pere Domingo; Rosario Palacios; Jesús Santos; María Jesús Pérez-Elías; Rainel Sánchez-de la Rosa; Celia Miralles; Antonio Antela; Santiago Moreno
Sustained improvement of dyslipidaemia in HAART-treated patients replacing stavudine with tenofovir.
AIDS (London, England) 2006;20(10):1407-14.
2006: Fernando Dronda; Antonio Antela; María Jesús Pérez-Elías; José L Casado; Ana Moreno; Santiago Moreno
Rescue therapy with once-daily atazanavir-based regimens for antiretroviral-experienced HIV-infected patients.
Journal of acquired immune deficiency syndromes (1999) 2006;42(2):258-9.
2006: Maria Pernas; Concepcion Casado; Rosa Fuentes; María Jesús Pérez-Elías; Cecilio López-Galíndez
A dual superinfection and recombination within HIV-1 subtype B 12 years after primoinfection.
Journal of acquired immune deficiency syndromes (1999) 2006;42(1):12-8.
2006: Juan Berenguer; María Jesús Pérez-Elías; José M Bellón; Hernando Knobel; Pablo Rivas-González; José M Gatell; Máximo Miguélez; José Hernández Quero; Juan Flores; Vicente Soriano; Ignacio Santos; Daniel Podzamczer; Monserrat Sala; Manuel Camba; Salvador Resino
Effectiveness and safety of abacavir, lamivudine, and zidovudine in antiretroviral therapy-naive HIV-infected patients: results from a large multicenter observational cohort.
Journal of acquired immune deficiency syndromes (1999) 2006;41(2):154-9.
2005: María Jesús Pérez-Elías; Ana Moreno; Santiago Moreno; Dolores López; Antonio Antela; José L Casado; Fernando Dronda; Carolina Gutiérrez; Carmen Quereda; Enrique Navas; Víctor Abraira; Miguel Angel Rodríguez
Higher virological effectiveness of NNRTI-based antiretroviral regimens containing nevirapine or efavirenz compared to a triple NRTI regimen as initial therapy in HIV-1-infected adults.
HIV clinical trials 2005;6(6):312-9.
2005: José R Foruny; Jesús Blázquez; Ana Moreno; Rafael Bárcena; Luis Gil-Grande; Carmen Quereda; María Jesús Pérez-Elías; Javier Moreno; Juan Sánchez; Alfonso Muriel; Miguel A Rodriguez-Sagrado; Santiago Moreno
Safe use of pegylated interferon/ribavirin in hepatitis C virus cirrhotic patients with hypersplenism after partial splenic embolization.
European journal of gastroenterology & hepatology 2005;17(11):1157-64.
2005: Jesús Fortún; Pilar Martín-Dávila; Enrique Navas; María Jesús Pérez-Elías; Javier Cobo; Marta Tato; Elia Gómez-G de la Pedrosa; Enrique Gómez-Mampaso; Santiago Moreno
Linezolid for the treatment of multidrug-resistant tuberculosis.
The Journal of antimicrobial chemotherapy 2005;56(1):180-5.
2005: María Jesús Pérez-Elías; Santiago Moreno; Carolina Gutiérrez; Dolores López; Víctor Abraira; Ana Moreno; Fernando Dronda; José L Casado; Antonio Antela; Miguel Angel Rodríguez
High virological failure rate in HIV patients after switching to a regimen with two nucleoside reverse transcriptase inhibitors plus tenofovir.
AIDS (London, England) 2005;19(7):695-8.
2005: Santiago Moreno; Jesús Fortún; Carmen Quereda; Ana Moreno; María Jesús Pérez-Elías; Pilar Martín-Dávila; Emilio de Vicente; Rafael Bárcena; Yolanda Quijano; Miguel García; Javier Nuño; Adolfo Martínez
Liver transplantation in HIV-infected recipients.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2005;11(1):76-81.
2004: Fernando Dronda; Javier Zamora; Santiago Moreno; Ana Moreno; José L Casado; Alfonso Muriel; María Jesús Pérez-Elías; Antonio Antela; Leonor Moreno; Carmen Quereda
CD4 cell recovery during successful antiretroviral therapy in naive HIV-infected patients: the role of intravenous drug use.
AIDS (London, England) 2004;18(16):2210-2.
2004: Iñigo Corral; Carmen Quereda; Enrique Navas; Pilar Martín-Dávila; María Jesús Pérez-Elías; José L Casado; Vicente Pintado; Javier Cobo; Esperanza Pallarés; José Rubí; Santiago Moreno
Adenosine deaminase activity in cerebrospinal fluid of HIV-infected patients: limited value for diagnosis of tuberculous meningitis.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2004;23(6):471-6.
2004: Iñigo Corral; Carmen Quereda; Mercedes García-Villanueva; José L Casado; María Jesús Pérez-Elías; Enrique Navas; Aurelio Ariza; Santiago Moreno
Focal monophasic demyelinating leukoencephalopathy in advanced HIV infection.
European neurology 2004;52(1):36-41.
2003: María Jesús Pérez-Elías; Ana Moreno; Santiago Moreno; Antonio Antela; Fernando Dronda; Vicente Muñoz; José L Casado; Carmen Quereda; Dolores Lopez; Enrique Navas
Differences in durability of treatment with initial PI-based regimens.
HIV clinical trials 2003;4(6):391-9.
2003: Santiago Moreno; José L Casado; María Jesús Pérez-Elías; Fernando Dronda; Antonio Antela; Ana Moreno; Carolina Gutiérrez
Hypersusceptibility to non-nucleoside reverse transcriptase inhibitors in HIV-1.
AIDS (London, England) 2003;17(9):1413-4.
2003: Iñigo Corral; Carmen Quereda; María Jesús Pérez-Elías; Santiago Moreno
Search for human herpesvirus 6 DNA in cerebrospinal fluid from AIDS patients with progressive multifocal leukoencephalopathy.
Journal of neurovirology 2003;9(1):136-7.
2002: Fernando Dronda; Santiago Moreno; Ana Moreno; José L Casado; María Jesús Pérez-Elías; Antonio Antela
Long-term outcomes among antiretroviral-naive human immunodeficiency virus-infected patients with small increases in CD4+ cell counts after successful virologic suppression.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2002;35(8):1005-9.
2002: Fernando Dronda; Santiago Moreno; María Jesús Pérez-Elías; José L Casado; Antonio Antela; Ana Moreno
Vascular disease in HIV-infected patients: a comparative study of two different therapeutic periods (1994-1997 versus 1998-2000).
AIDS (London, England) 2002;16(14):1971-3.
2002: Melcior Riera; Maria Angels Ribas; María Jesús Pérez-Elías; Josep Mallolas; Joaquim Portilla; Pompeyo E. Viciana
[Approach to treatment of patients with virologic failure to multiple regimens].
Enfermedades infecciosas y microbiología clínica 2002;20 Suppl 2():58-67.
2002: Enrique Navas; Pilar Martín-Dávila; Leonor Moreno; Vicente Pintado; José L Casado; Jesús Fortún; María Jesús Pérez-Elías; Enrique Gomez-Mampaso; Santiago Moreno
Paradoxical reactions of tuberculosis in patients with the acquired immunodeficiency syndrome who are treated with highly active antiretroviral therapy.
Archives of internal medicine 2002;162(1):97-9.
2001: M A Cañizares; Isabel Losada; María Jesús Pérez-Elías; J González; R Rubio; José L Casado; A Guerrero
[Cytomegalovirus sensitivity to anti-retroviral agents in patients infected with the human immunodeficiency virus with chorioretinitis in Spain].
Enfermedades infecciosas y microbiología clínica 2001;19(10):471-4.
2001: Oscar Gallego; Carmen de Mendoza; María Jesús Pérez-Elías; J M Guardiola; José Pedreira; David Dalmau; J Gónzalez; A Moreno; José R Arribas; Amalia Rubio; I García-Arata; Manuel Leal; Pere Domingo; Vincent Soriano
Drug resistance in patients experiencing early virological failure under a triple combination including indinavir.
AIDS (London, England) 2001;15(13):1701-6.
2001: Fernando Dronda; José L Casado; Santiago Moreno; Kurt Hertogs; I García-Arata; Antonio Antela; María Jesús Pérez-Elías; L Ruiz; Brendan Larder
Phenotypic cross-resistance to nelfinavir: the role of prior antiretroviral therapy and the number of mutations in the protease gene.
AIDS research and human retroviruses 2001;17(3):211-5.
2000: María Jesús Pérez-Elías; R Lanier; Vicente Muñoz; I Garcia-Arata; José L Casado; P Marti-Belda; A Moreno; Fernando Dronda; Antonio Antela; S Marco; Santiago Moreno
Phenotypic testing predicts virological response in successive protease inhibitor-based regimens.
AIDS (London, England) 2000;14(9):F95-101.
1999: J Cobo Reinoso; Pilar Martín-Dávila; A Antela López; María Jesús Pérez-Elías
[Impact of protease inhibitors on hospitalization in an Infectious Disease Unit].
Revista clínica española 1999;199(8):547-9.
1999: S Moreno Guillén; María Jesús Pérez-Elías
[Clinical and economic impact of new antiretroviral treatments].
Revista clínica española 1999;199(2):53-4.
1999: Fernando Dronda; María Jesús Pérez-Elías; Antonio Antela; José L Casado; Paloma Martí-Belda; J Cobo
Patients failing saquinavir therapy require an early change to indinavir before HIV-1 viral load reaches high levels.
Antiviral therapy 1999;4(2):117-21.
1997: Antonio Antela; José L Casado; M J González; P Pérez; María Jesús Pérez-Elías; P Montilla; L Buzón
Influence of a methadone maintenance programme on the improved outcome of a cohort on injecting drug users with advanced HIV disease.
AIDS (London, England) 1997;11(11):1405-6.
1997: Iñigo Corral; Carmen Quereda; José L Casado; Javier Cobo; Enrique Navas; María Jesús Pérez-Elías; Vicente Pintado; Jesús Fortún; Antonio Guerrero
Acute polyradiculopathies in HIV-infected patients.
Journal of neurology 1997;244(8):499-504.
1997: F Galbis Sanjuan; Miguel Jiménez Cidre; R Rodríguez Rodríguez; María Jesús Pérez-Elías; V Gómez do Santos; J A Rivas Escudero
[Tuberculous prostatic abscess in acquired immunodeficiency syndrome].
Archivos españoles de urología 1997;50(4):393-5.
1996: Javier Cobo; M F Ruiz; M S Figueroa; Antonio Antela; Carmen Quereda; María Jesús Pérez-Elías; Iñigo Corral; Antonio Guerrero
Retinal toxicity associated with didanosine in HIV-infected adults.
AIDS (London, England) 1996;10(11):1297-300.
1993: Antonio Antela; Antonio Guerrero; María Antonia Meseguer; J González-Sainz; R Escudero; María Jesús Pérez-Elías; Carmen Quereda; J M Hermida; Javier Cobo; P Montilla
[Community-acquired pneumonia: prospective study of 101 adult, immunocompetent patients for 1 year].
Enfermedades infecciosas y microbiología clínica 1993;11(10):525-30.
1993: Antonio Antela; Antonio Guerrero; P Montilla; J M Hermida; Jesús Fortún; María Jesús Pérez-Elías; Carmen Quereda; Enrique Navas
[Roxithromycin in the treatment of community-acquired pneumonia].
Enfermedades infecciosas y microbiología clínica 1993;11(5):260-2.
1992: Jesús Fortún; Enrique Navas; Paloma Martí-Belda; P Montilla; J M Hermida; María Jesús Pérez-Elías; L Buzón; Antonio Guerrero
Pneumocystis carinii pneumonia in HIV-infected patients: diagnostic yield of induced sputum and immunofluorescent stain with monoclonal antibodies.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 1992;5(6):665-9.
1991: C Quereda; A Guerrero; E Navas; María Jesús Pérez-Elías
Concomitant tuberculous and staphylococcal osteomyelitis.
Archives of internal medicine 1991;151(11):2314.
1989: Fernando Dronda; M Jiménez; P Montilla de Mora; F Pérez-Hernández; María Jesús Pérez-Elías; S Moreno; J Sanz; F Martínez
[Pneumococcal endocarditis: apropos of 3 cases].
Enfermedades infecciosas y microbiología clínica 1989;7(6):321-3.
1989: L Torroba; P Montilla; María Jesús Pérez-Elías; Carmen Quereda; L Buzón
[Bacteremia of urinary origin complicated with cerebral abscess].
Enfermedades infecciosas y microbiología clínica 1989;7(4):231.